DRUG · Unmapped registry intervention
CDK4/6 inhibitor
Find medicine records ·
Find other trials using this name
Clinical trial
Adjuvant CDK4/6 Inhibitor Use in HR+/HER2- Breast Cancer
NCT07180056
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedAdjuvant CDK4/6 Inhibitor Use in HR+/HER2- Breast Cancer
Design: OBSERVATIONAL · Status: RECRUITING · Phase: Not specified
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Breast Cancerverified · MONDO: breast cancer
Interventions
CDK4/6 inhibitorDRUG
Sponsors & collaborators
Wenjin Yinlead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT07180056 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.